Mechanical Ventilation — Principles

• Alveolar Pressure and Bulk Flow of Gas: During spontaneous breathing, the diaphragm contracts, creating negative intrathoracic pressure that draws air passively into the lungs down a pressure gradient. Mechanical ventilation reverses this paradigm by delivering positive pressure at the airway opening, directly pushing gas into the lungs. According to the pressure gradient equation (Flow = ΔP/Resistance), air flows from the ventilator (higher pressure) through the airways into alveoli (lower pressure), bypassing the need for spontaneous diaphragmatic effort. The magnitude of alveolar pressure elevation depends on both the applied pressure and lung compliance (ΔV/ΔP), the elastic properties of the lungs and chest wall. Lungs with reduced compliance (as in ARDS, pulmonary fibrosis, or edema) require higher driving pressures to achieve adequate tidal volumes, increasing risk for barotrauma.

• Tidal Volume, Minute Ventilation, and Alveolar Ventilation: Minute ventilation (V̇E) equals the respiratory rate multiplied by tidal volume (V̇E = RR × Vt). However, not all inspired gas participates in gas exchange. Anatomical dead space (approximately 150 mL or ~2 mL/kg in adults) represents airways that do not participate in gas exchange. Alveolar ventilation (V̇A) is the clinically relevant parameter for CO₂ elimination: V̇A = (Vt − Vdead) × RR. When tidal volumes are reduced (as during lung-protective ventilation strategies), the proportion of dead space ventilation increases, potentially resulting in inadequate CO₂ elimination despite maintenance of minute ventilation. This explains why patients transitioned to lower tidal volumes may require increased respiratory rates to maintain eucapnia. The relationship between V̇A and PaCO₂ is inverse and exponential: PaCO₂ ≈ (VCO₂ produced / V̇A) × 0.863, meaning small decrements in alveolar ventilation cause disproportionate increases in PaCO₂.

• Oxygenation, FiO₂, and the Alveolar Gas Equation: The alveolar oxygen partial pressure (PAO₂) is determined by the alveolar air equation: PAO₂ = (PB − PH₂O) × FiO₂ − (PaCO₂/R), where PB is barometric pressure, PH₂O is water vapor pressure (47 mmHg at sea level), FiO₂ is fraction of inspired oxygen, and R is the respiratory quotient (typically 0.8). Increasing FiO₂ (via higher oxygen concentration in inspired gas) directly increases PAO₂ and therefore PaO₂. However, the A-a gradient [A-a DO₂ = PAO₂ − PaO₂] reveals the efficiency of oxygen transfer from alveoli to blood; widening A-a gradients indicate impaired diffusion, intrapulmonary shunting, or ventilation-perfusion (V̇/Q̇) mismatch. In healthy individuals, A-a DO₂ is <10 mmHg; in ARDS or severe pneumonia, it may exceed 300 mmHg. Positive end-expiratory pressure (PEEP) improves oxygenation by maintaining alveolar recruitment—preventing alveolar collapse at end-expiration and redistributing fluid away from dependent lung regions—thereby reducing shunt fraction and widening A-a DO₂.

• Lung Compliance and Resistance: The elastic recoil of the lungs is characterized by static compliance (Cs = ΔV / ΔPplat − PEEP), measured during an inspiratory pause when no airflow occurs. Dynamic compliance (Cd = Vt / Ppeak − PEEP) includes the effects of airway resistance. Conditions that reduce compliance include ARDS, atelectasis, pulmonary fibrosis, pulmonary edema, and chest wall restriction (obesity, ascites). Airway resistance opposes airflow and is inversely related to the fourth power of airway radius (R = 8ηL/πr⁴, Poiseuille's law); thus, small reductions in airway caliber (asthma, COPD exacerbation, secretion plugging) cause marked increases in resistance and work of breathing. High airway resistance increases the peak inspiratory pressure (Ppeak) relative to plateau pressure (Pplat), creating the characteristic "pressure gradient" seen in obstructive disease. The work of breathing is performed either by the ventilator or the patient's respiratory muscles; excessive work of breathing increases metabolic demand and can prolong weaning from mechanical ventilation.

• Pressure-Volume Relationships and Ventilator-Induced Lung Injury (VILI): The lungs do not follow linear pressure-volume relationships; instead, they exhibit a sigmoid curve with a lower inflection point (LIP) and upper inflection point (UIP). Below the LIP, large pressure increments are needed to recruit closed alveoli (recruitment-derecruitment). Above the UIP, further pressure increases cause alveolar overdistension with minimal volume gain. Excessive plateau pressures (Pplat > 30 cmH₂O) cause barotrauma/volutrauma through direct alveolar rupture, leading to pneumothorax, pneumomediastinum, or subcutaneous emphysema. Atelectrauma results from cyclic opening and closing of alveoli below the LIP, causing shear stress and epithelial injury. Biotrauma refers to ventilator-induced release of inflammatory mediators (TNF-α, IL-6, IL-8) from mechanically stressed alveolar epithelium, which enter the systemic circulation and contribute to multi-organ dysfunction. Lung-protective ventilation strategies minimize VILI by using lower tidal volumes (6–8 mL/kg ideal body weight), permissive hypercapnia, and optimal PEEP titration to minimize atelectasis while avoiding overdistension.

• Positive Pressure, Intrathoracic Pressure, and Hemodynamic Effects: Mechanical ventilation converts negative intrathoracic pressure (normal spontaneous breathing) to positive intrathoracic pressure, with profound hemodynamic consequences. Increased intrathoracic pressure is transmitted to the heart and great vessels, decreasing venous return to the right atrium (preload), which reduces right ventricular stroke volume. In hypovolemic patients or those with right ventricular dysfunction, this can cause acute hypotension during mechanical ventilation initiation. Positive pressure also increases right ventricular afterload by compressing pulmonary vessels. Increased intrathoracic pressure may also impede left ventricular filling during diastole (ventricular interdependence). These hemodynamic effects are exacerbated by high tidal volumes, high respiratory rates, and high PEEP levels. Conversely, in acutely decompensated heart failure with pulmonary edema, positive pressure ventilation can reduce afterload on the left ventricle and improve LV function by decreasing transmural pressure. Understanding these hemodynamic interactions is essential when initiating mechanical ventilation in hemodynamically unstable patients.

• Hypoxemic Respiratory Failure (Type I): This is characterized by PaO₂ < 60 mmHg despite supplemental oxygen (FiO₂ ≥ 0.5), usually with preserved or low-normal PaCO₂. Primary etiologies include acute respiratory distress syndrome (ARDS) from sepsis, aspiration, trauma, transfusion-related acute lung injury (TRALI), or pneumonia; acute pulmonary embolism; acute coronary syndrome with cardiogenic pulmonary edema; diffuse interstitial lung disease; and severe pneumonia (bacterial, viral, or opportunistic). The underlying mechanism is typically intrapulmonary shunting (blood perfusing non-ventilated lung units), V̇/Q̇ mismatch, or impaired diffusion. These conditions exhibit a widened A-a DO₂ that does not normalize with supplemental oxygen alone, necessitating mechanical ventilation to recruit collapsed alveoli and improve oxygenation.

• Hypercapnic Respiratory Failure (Type II): This is defined by PaCO₂ > 50 mmHg with pH < 7.25, reflecting inadequate alveolar ventilation. Causes include: (1) Decreased level of consciousness (drug overdose, general anesthesia, severe CNS injury, hepatic encephalopathy), which eliminates volitional respiratory drive; (2) Neuromuscular weakness (Guillain-Barré syndrome, myasthenia gravis, spinal cord injury, critical illness myopathy/polyneuropathy), which reduces diaphragmatic force generation; (3) Chest wall/pleural disease (flail chest, massive ascites, severe obesity, kyphoscoliosis), which increases elastic work of breathing beyond patient capacity; (4) Obstructive airways disease (severe asthma exacerbation, acute COPD exacerbation with CO₂ retention), where high airway resistance increases the mechanical work of breathing; and (5) Central hypoventilation (congenital central hypoventilation syndrome, severe sleep apnea, hypothyroidism). In Type II failure, the primary problem is inadequate minute ventilation rather than oxygenation failure.

• Combined Respiratory Failure (Type III): This occurs in conditions causing both hypoxemia and hypercapnia, such as severe pneumonia, ARDS with underlying COPD, or extensive aspiration. Mechanical ventilation is essential because neither oxygenation nor ventilation can be maintained spontaneously.

• Perioperative and Sedation-Related Indications: Patients undergoing major surgery are routinely intubated and mechanically ventilated under general anesthesia. Anesthetic agents (propofol, volatile anesthetics, opioids) suppress respiratory drive and cause marked decreases in functional residual capacity (FRC), predisposing to intraoperative hypoxemia. Mechanical ventilation maintains oxygenation and ventilation during this period of intentional sedation. Post-extubation, some patients (particularly those with significant comorbidities, lengthy surgical times, or upper airway obstruction) may require re-intubation if respiratory failure develops.

• Risk Factors for Requiring Mechanical Ventilation: Advanced age, severe underlying lung disease (COPD, interstitial lung disease), cardiac disease, renal failure, immunosuppression, obesity, and prolonged ICU stay are associated with increased need for mechanical ventilation and difficulty with weaning. In sepsis, the presence of organ dysfunction (as quantified by SOFA score) predicts the likelihood of requiring mechanical ventilation.

• Respiratory Distress: Patients typically present with dyspnea, tachypnea, and increased work of breathing. Tachypnea (RR > 30/min) is a sensitive sign of respiratory inadequacy and often triggers evaluation for respiratory failure. Accessory muscle use (sternocleidomastoid, scalene muscles) indicates that patients are recruiting supplemental muscles, signifying high respiratory effort. Paradoxical breathing (abdominal movement inward during inspiration) suggests severe inspiratory effort and impending fatigue. Retractions (suprasternal, intercostal, subcostal) are particularly notable in children and indicate increased pleural pressure swings. In COPD exacerbations, pursed-lip breathing reflects patients' intuitive attempt to generate back-pressure and maintain positive airway pressure (auto-PEEP) to prevent dynamic airway collapse.

• Hypoxemia: Patients develop cyanosis (bluish discoloration of lips, oral mucosa, nail beds) when deoxygenated hemoglobin exceeds 5 g/dL (approximately SaO₂ < 85% in patients with normal hemoglobin). Peripheral oxygen saturation (SpO₂) by pulse oximetry may be falsely reassuring early in hypoxemia due to the flat upper portion of the hemoglobin-oxygen dissociation curve; patients can maintain SpO₂ 90–94% despite significant hypoxemia (PaO₂ 55–65 mmHg). Acute hypoxemia triggers compensatory tachycardia and increased cardiac output; if severe or prolonged, it leads to altered mental status, seizures, and arrhythmias.

• Hypercapnia: Acute elevation of PaCO₂ causes a constellation of neurologic and hemodynamic manifestations. The CO₂-induced acidosis depresses the CNS, causing somnolence, confusion, and obtundation—the "CO₂ narcosis" seen in acute COPD exacerbations or in sedated patients with inadequate ventilation. Hypercapnia causes cerebral vasodilation, increasing intracranial pressure; patients may report headache or demonstrate papilledema. Hemodynamic effects include sympathetic activation (tachycardia, hypertension) from catecholamine release, though severe hypercapnia paradoxically depresses myocardial contractility. Tremor ("flapping tremor" or asterixis) reflects metabolic encephalopathy and is classically observed in CO₂ narcosis or hepatic encephalopathy.

• Altered Mental Status: Patients with respiratory failure from any cause frequently present with confusion, agitation, or lethargy. In hypoxemic failure, this reflects inadequate cerebral oxygen delivery. In hypercapnic failure, it represents CO₂ narcosis. Metabolic encephalopathy from sepsis, uremia, hepatic failure, or hypoglycemia commonly coexists with respiratory failure and may be the primary indication for intubation (to protect the airway). Distinguishing between hypoxemia, hypercapnia, and other metabolic causes of altered mental status requires arterial blood gas analysis combined with appropriate laboratory studies.

• Stridor and Upper Airway Compromise: Patients with inspiratory stridor (high-pitched breathing sound, more audible during inspiration) have upper airway obstruction, typically from epiglottitis, angioedema, vocal cord dysfunction, or foreign body aspiration. Biphasic stridor suggests fixed obstruction (web, tumor, stenosis). These presentations require urgent airway management; prolonged attempts at non-invasive ventilation may delay necessary intubation. In contrast, wheezing (musical, lower-pitched sound) reflects intrathoracic airway obstruction and is typical of asthma or COPD exacerbations, which may initially respond to bronchodilators and steroids without intubation.

• Shock and Hemodynamic Instability: Patients with severe sepsis, cardiogenic shock, or massive pulmonary embolism may present with hypotension, cool extremities, altered perfusion, and elevated lactate. The need for mechanical ventilation in this context reflects both the underlying critical illness and the hemodynamic burden of respiratory effort. Initiating mechanical ventilation (paradoxically) may improve hemodynamics by off-loading the respiratory muscles and redirecting cardiac output away from respiratory work toward vital organs, though the positive intrathoracic pressure itself may transiently decrease preload and blood pressure.

• Audible Secretions and Inability to Protect Airway: Patients with gurgling respirations ("wet secretions"), inability to c

Establishing the need

• Arterial blood gas: the confirmatory test. Hypoxemic (Type I) failure shows PaO₂ < 60 mmHg with a widened A–a gradient; hypercapnic (Type II) failure shows PaCO₂ > 50 mmHg with pH < 7.25. An acutely low pH with high PaCO₂ separates acute from chronic compensated hypercapnia (normal pH, elevated bicarbonate).
• Pulse oximetry and capnography: screening and trend tools. SpO₂ is insensitive early because of the flat upper hemoglobin–oxygen curve, so a normal-appearing saturation does not exclude failure.
• Chest radiograph and bedside ultrasound: identify the cause (bilateral opacities, consolidation, pneumothorax, effusion) and confirm endotracheal tube position.
• PaO₂/FiO₂ ratio: the oxygenation index that defines ARDS severity.

Named criteria

• ***Berlin definition* of ARDS**: onset within one week of an insult, bilateral opacities not fully explained by effusion/collapse/nodules, respiratory failure not fully explained by cardiac failure or volume overload (echocardiography if needed), and P/F ≤ 300 on PEEP ≥ 5 cmH₂O — mild 200–300, moderate 100–200, severe ≤ 100.

Confirming the airway

• Waveform capnography is the gold standard for endotracheal tube placement (sustained exhaled CO₂ over several breaths); the radiograph then confirms depth, with the tip several centimeters above the carina. Right mainstem intubation gives absent left breath sounds and left-sided volume loss.

Ventilator mechanics at the bedside

• Inspiratory hold gives plateau pressure (alveolar distending pressure; keep ≤ 30 cmH₂O). Peak pressure reflects resistance plus compliance.
• High Ppeak with normal Pplat = resistance problem; high Ppeak with high Pplat = compliance problem.
• Expiratory hold unmasks auto-PEEP (intrinsic PEEP) in obstructive disease; the flow–time waveform shows expiratory flow that fails to return to zero.
• Driving pressure (Pplat − PEEP) correlates with ventilator-induced lung injury risk.

Before intubation — trial non-invasive support when appropriate

• Non-invasive positive pressure ventilation (BiPAP): strongest evidence in acute hypercapnic COPD exacerbation (endorsed by GOLD and the ERS/ATS non-invasive ventilation guideline) and in cardiogenic pulmonary edema, where positive intrathoracic pressure reduces LV transmural pressure and afterload.
• High-flow nasal cannula: preferred over conventional oxygen in acute hypoxemic (non-hypercapnic) failure per the ERS/ATS guidance.
• Contraindicated: obtundation with inability to protect the airway, active vomiting or GI bleeding, facial trauma, cardiac arrest, and refractory shock. Persisting with non-invasive support in a deteriorating patient delays definitive airway control.

Intubation

• Rapid-sequence intubation: an induction agent (etomidate or ketamine, both relatively hemodynamically neutral) plus a paralytic (succinylcholine, or rocuronium when hyperkalemia, crush injury, or denervation makes depolarizing block unsafe). Pre-oxygenate and anticipate post-intubation hypotension from loss of sympathetic tone plus reduced venous return — give fluids and have a vasopressor ready.

Initial settings (lung-protective, ARDSNet strategy endorsed by ATS/ESICM/SCCM)

• Volume assist-control with tidal volume 6 mL/kg predicted body weight — calculated from height and sex, never actual weight.
• Plateau pressure ≤ 30 cmH₂O; increase respiratory rate to compensate for the smaller tidal volume, accepting permissive hypercapnia as long as pH stays acceptable.
• PEEP/FiO₂ titrated together to an oxygenation target in the SpO₂ 88–95% range.

Escalation in refractory hypoxemia

• Prone positioning for ≥ 16 hours/day in moderate-to-severe ARDS (P/F < 150) — a mortality-reducing intervention (PROSEVA).
• Neuromuscular blockade for severe dyssynchrony; inhaled pulmonary vasodilators improve oxygenation without proven mortality benefit; veno-venous ECMO at experienced centers as rescue.
• In obstructive disease, treat auto-PEEP by lengthening expiratory time (lower rate, higher inspiratory flow) and by aggressive bronchodilation.

Liberation

• Per the ATS/CHEST liberation guideline and the SCCM PADIS/ABCDEF bundle: light sedation, daily spontaneous awakening trials paired with spontaneous breathing trials, early mobility, and extubation to preventive non-invasive ventilation in high-risk patients. Avoid deep continuous benzodiazepine sedation, which prolongs ventilation and worsens delirium.

Ventilator-induced lung injury

• Barotrauma/volutrauma: alveolar overdistension above the upper inflection point ruptures alveoli. Signals: sudden rise in peak and plateau pressure, hypotension, unilateral absent breath sounds, subcutaneous emphysema or pneumomediastinum. Tension pneumothorax is an emergency — needle decompression/chest tube before imaging.
• Atelectrauma: cyclic recruitment–derecruitment causes shear injury; prevented by adequate PEEP.
• Biotrauma: mediator release (TNF-α, IL-6) from stressed epithelium drives distant organ failure.

Hemodynamic and gas-trapping emergencies

• Auto-PEEP with dynamic hyperinflation: incomplete exhalation raises intrathoracic pressure, collapses venous return, and can mimic cardiac arrest in an asthmatic. Emergency: disconnect the patient from the circuit and allow passive exhalation, then reduce rate and tidal volume.
• Post-intubation hypotension: sedation-induced vasodilation plus positive pressure reducing preload; worst in hypovolemia, tamponade, and RV failure.

Airway and device complications

• Right mainstem intubation: left lung collapse with right-sided hyperinflation.
• Ventilator-associated pneumonia: microaspiration around the cuff; new infiltrate, fever, purulent secretions, rising oxygen requirement. Head-of-bed elevation and minimizing sedation reduce risk.
• Laryngeal edema, ulceration, and late tracheal stenosis from cuff pressure; post-extubation stridor with a failed cuff-leak test predicts it. Endotracheal tube obstruction or dislodgement presents as sudden high peak pressure with normal plateau — recall the DOPE mnemonic (Displacement, Obstruction, Pneumothorax, Equipment failure).

Systemic and neuromuscular

• Ventilator-induced diaphragmatic dysfunction from disuse atrophy, and ICU-acquired weakness from immobility, steroids, and neuromuscular blockade — both prolong weaning.
• Delirium from sedation and sleep disruption; addressed by the SCCM PADIS/ABCDEF bundle.
• Oxygen toxicity and absorption atelectasis with prolonged high FiO₂; free-radical alveolar injury.
• Stress ulceration and venous thromboembolism in immobilized ventilated patients, the rationale for prophylaxis per Surviving Sepsis Campaign practice.

• Tidal volume is dosed to predicted body weight: 6 mL/kg PBW calculated from height and sex. Using actual body weight in an obese patient is the classic distractor and produces injurious volumes.
• Peak versus plateau is the single most tested ventilator concept: high peak with normal plateau = an airway resistance problem (bronchospasm, mucus plug, kinked or biting on the tube); high peak with high plateau = a compliance problem (pneumothorax, pulmonary edema, ARDS, mainstem intubation, abdominal distension).
• Sudden hypotension plus rising pressures in a ventilated asthmatic: think auto-PEEP or tension pneumothorax. The best next step for suspected breath-stacking is to disconnect the circuit and let the patient exhale; for tension pneumothorax it is immediate needle decompression, not a chest x-ray.
• Waveform capnography confirms endotracheal tube placement, not auscultation or the chest film — the film only confirms depth.
• Berlin criteria define ARDS: acute onset, bilateral opacities, not explained by cardiogenic edema, and P/F ≤ 300 on PEEP ≥ 5. Severe disease (P/F < 150) is the trigger for prone positioning ≥ 16 h/day, one of the few interventions with a mortality benefit (PROSEVA).
• Refractory hypoxemia that barely improves with 100% FiO₂ = intrapulmonary shunt — the fix is recruitment (PEEP, prone), not more oxygen.
• Weaning: a spontaneous breathing trial paired with a spontaneous awakening trial is the ATS/CHEST-endorsed approach; a rapid shallow breathing index (RR/Vt in liters) under roughly 105 favors successful extubation, but the SBT itself — not the index — drives the decision.
• Permissive hypercapnia is acceptable to protect the lung, but avoid it when intracranial pressure is elevated, since CO₂-induced cerebral vasodilation worsens ICP.